Cargando…

Inflammasome Activation in Parkinson’s Disease

Chronic sterile inflammation and persistent immune activation is a prominent pathological feature of Parkinson’s disease (PD). Inflammasomes are multi-protein intracellular signaling complexes which orchestrate inflammatory responses in immune cells to a diverse range of pathogens and host-derived s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jewell, Shannon, Herath, Ashane M., Gordon, Richard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9535572/ https://www.ncbi.nlm.nih.gov/pubmed/35848038 http://dx.doi.org/10.3233/JPD-223338

Ejemplares similares

Targeting the inflammasome in Parkinson’s disease
por: Su, Qi, et al.
Publicado: (2022)

Role of NLRP3 Inflammasome in Parkinson’s Disease and Therapeutic Considerations
por: Nguyen, Linh Thi Nhat, et al.
Publicado: (2022)

Plasma-borne indicators of inflammasome activity in Parkinson’s disease patients
por: Anderson, Faith L., et al.
Publicado: (2021)

NLRP3 Inflammasome-Mediated Neuroinflammation and Related Mitochondrial Impairment in Parkinson’s Disease
por: Han, Qiu-Qin, et al.
Publicado: (2023)

The potential convergence of NLRP3 inflammasome, potassium, and dopamine mechanisms in Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

Dopamine signaling modulates microglial NLRP3 inflammasome activation: implications for Parkinson’s disease
por: Pike, Adrianne F., et al.
Publicado: (2022)

The cell biology of inflammasomes: Mechanisms of inflammasome activation and regulation
por: Sharma, Deepika, et al.
Publicado: (2016)

Omnipresence of inflammasome activities in inflammatory bone diseases
por: Alippe, Yael, et al.
Publicado: (2019)

BAG3 promotes autophagy and suppresses NLRP3 inflammasome activation in Parkinson’s disease
por: Ying, Zhong-Ming, et al.
Publicado: (2022)

Fyn amplifies NLRP3 inflammasome signaling in Parkinson's disease
por: Panicker, Nikhil, et al.
Publicado: (2019)

Toll-like receptors and NLRP3 inflammasome-dependent pathways in Parkinson’s disease: mechanisms and therapeutic implications
por: Soraci, Luca, et al.
Publicado: (2022)

The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases
por: Arioz, Burak Ibrahim, et al.
Publicado: (2021)

The mechanism behind activation of the Nod-like receptor family protein 3 inflammasome in Parkinson’s disease
por: Wang, Jing, et al.
Publicado: (2021)

A Novel Treatment Strategy by Natural Products in NLRP3 Inflammasome-Mediated Neuroinflammation in Alzheimer’s and Parkinson’s Disease
por: Lee, Jun Ho, et al.
Publicado: (2021)

Activation and Pharmacological Regulation of Inflammasomes
por: Chen, Chen, et al.
Publicado: (2022)

Dysregulation of inflammasome activation in glioma
por: Sim, JeongMin, et al.
Publicado: (2023)

Interaction between autophagy and the NLRP3 inflammasome in Alzheimer’s and Parkinson’s disease
por: Lu, Ranran, et al.
Publicado: (2022)

Flavonoids: Nutraceuticals for Rheumatic Diseases via Targeting of Inflammasome Activation
por: Yi, Young-Su
Publicado: (2021)

Neutrophils in Health and Disease: From Receptor Sensing to Inflammasome Activation
por: Iwaniuk, Agnieszka, et al.
Publicado: (2023)

Inflammasomes in neuroinflammatory and neurodegenerative diseases
por: Voet, Sofie, et al.
Publicado: (2019)

The Role of the Inflammasome in Neurodegenerative Diseases
por: Piancone, Federica, et al.
Publicado: (2021)

Inflammasomes in the Pathophysiology of Aortic Disease
por: Wortmann, Markus, et al.
Publicado: (2021)

Potential Therapeutic Use of the Rosemary Diterpene Carnosic Acid for Alzheimer’s Disease, Parkinson’s Disease, and Long-COVID through NRF2 Activation to Counteract the NLRP3 Inflammasome
por: Satoh, Takumi, et al.
Publicado: (2022)

Promiscuous Inflammasomes: The False Dichotomy of RNA/DNA Virus-Induced Inflammasome Activation and Pyroptosis
por: Wallace, Hannah L., et al.
Publicado: (2022)

Of inflammasomes and pathogens – sensing of microbes by the inflammasome
por: Bauernfeind, Franz, et al.
Publicado: (2013)

NLRP3 Inflammasome’s Activation in Acute and Chronic Brain Diseases—An Update on Pathogenetic Mechanisms and Therapeutic Perspectives with Respect to Other Inflammasomes
por: Chiarini, Anna, et al.
Publicado: (2023)

Roles of ginsenosides in inflammasome activation
por: Yi, Young-Su
Publicado: (2019)

Infections and Changes in Commensal Bacteria and the Pathogenesis of Parkinson’s Disease
por: Shannon, Kathleen M.
Publicado: (2022)

ATP-Binding and Hydrolysis in Inflammasome Activation
por: Sandall, Christina F., et al.
Publicado: (2020)

Activation and Function of NLRP3 Inflammasome in Bone and Joint-Related Diseases
por: Murakami, Tomohiko, et al.
Publicado: (2022)

The Role of NLRP3 Inflammasome Activities in Bone Diseases and Vascular Calcification
por: Yu, Chenyang, et al.
Publicado: (2020)

Involvement of Inflammasome Components in Kidney Disease
por: Aranda-Rivera, Ana Karina, et al.
Publicado: (2022)

Inflammasomes—New Contributors to Blood Diseases
por: Tomasik, Jaromir, et al.
Publicado: (2022)

The Role of Inflammation and Inflammasome in Myeloproliferative Disease
por: Longhitano, Lucia, et al.
Publicado: (2020)

Inflammasome and Mitophagy Connection in Health and Disease
por: Yuk, Jae-Min, et al.
Publicado: (2020)

LncRNA MALAT1 facilitates inflammasome activation via epigenetic suppression of Nrf2 in Parkinson’s disease
por: Cai, Li-Jun, et al.
Publicado: (2020)

α-synuclein promotes progression of Parkinson's disease by upregulating autophagy signaling pathway to activate NLRP3 inflammasome
por: Wang, Xiaohong, et al.
Publicado: (2020)

Nutraceutical Compounds Targeting Inflammasomes in Human Diseases
por: Castejón-Vega, Beatriz, et al.
Publicado: (2020)

The Role of Inflammasomes in the Pathogenesis of Neurodegenerative Diseases
por: Shevchuk, D. V., et al.
Publicado: (2022)

The inflammasome and alum-mediated adjuvanticity
por: Kang, Suk-Jo, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_sv5806f794ccbnrb7coi5nkkha